Cost-Effectiveness of Intravenous Immunoglobulin (IVIG) Treatment in Patients with B-Cell Immunodeficiencies

被引：0
|
作者：
Smirnova, I. N. [1 ]
Kosacheva, T. G. [2 ]
Kuzmenko, N. B. [3 ]
Shcherbina, A. [1 ]
Novichkova, G. A. [3 ]
机构：
[1] Fed Res Ctr Pediat Hematol Oncol Immunol, Moscow, Russia
[2] Clin Childrens Hosp 9, Moscow, Russia
[3] Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2014年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
ESID-0482
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 50 条
  • [1] Immunoglobulin treatment for B-cell immunodeficiencies
    Freeman, Catherine M.
    Squire, Jacqueline D.
    Joshi, Avni Y.
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2022, 509
  • [2] Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
    Parwinder K. Gill
    Stephen D. Betschel
    [J]. Allergy, Asthma & Clinical Immunology, 14
  • [3] Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
    Gill, Parwinder K.
    Betschel, Stephen D.
    [J]. ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2018, 14
  • [4] Prolonged COVID-19 Infection in B-cell Impairment and Treatment With Intravenous Immunoglobulin (IVIG)
    Mehta, S.
    Grotberg, J. C.
    D'Alessandro, M.
    Arnold, E.
    Samant, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [5] Cost-effectiveness of rituximab in treatment of diffuse large B-cell lymphoma.
    Coiffier, B
    Best, JH
    Omnes, LF
    Hornberger, JC
    [J]. BLOOD, 2001, 98 (11) : 864A - 864A
  • [6] Cost-effectiveness of immunoglobulin therapies revealed at biennial European Society for Immunodeficiencies meeting
    Breeze, Sophie
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (06) : 681 - 681
  • [7] A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies
    de Albornoz, Sara Carrillo
    Chai, Khai Li
    Higgins, Alisa M.
    Petrie, Dennis
    Wood, Erica M.
    McQuilten, Zoe K.
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2024, 40 (01)
  • [8] THE COST-EFFECTIVENESS OF PRECISION MEDICINE TREATMENT STRATEGIES FOR DIFFUSE LARGE B-CELL LYMPHOMA
    Chen, Q.
    Staton, A. D.
    Ayer, T.
    Goldstein, D. A.
    Koff, J. L.
    Flowers, C. R.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A107 - A107
  • [9] Cost-Effectiveness of Subtype-Based Treatment Strategies for Diffuse Large B-Cell Lymphoma Patients (DLBCL)
    Staton, Ashley D.
    Chen, Qiushi
    Ayer, Turgay
    Goldstein, Daniel
    Koff, Jean L.
    Flowers, Christopher R.
    [J]. BLOOD, 2015, 126 (23)
  • [10] Cost-Effectiveness of Molecularly Guided Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) in Patients under 60
    Regier, Dean A.
    Chan, Brandon
    Costa, Sarah
    Scott, David W.
    Steidl, Christian
    Connors, Joseph M.
    Karsan, Aly
    Marra, Marco A.
    Kridel, Robert
    Cromwell, Ian
    Pollard, Samantha
    [J]. CANCERS, 2022, 14 (04)
12345